(Q42463524)

English

Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer

scientific article published on January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

blood–brain barrier

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Chikako Shimizu

4

object named as

Chikako Shimizu

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Yasuhiro Fujiwara

10

object named as

Yasuhiro Fujiwara

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1

object named as

Kan Yonemori

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Koji Tsuta

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Makiko Ono

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Akihiro Hirakawa

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Tadashi Hasegawa

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Yutaka Hatanaka

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Yoshitaka Narita

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Soichiro Shibui

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

302-308

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

21 January 2018

CNS metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab in CSF

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure, function, and regulation of the mammalian facilitative glucose transporter gene family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

The blood-brain barrier and cancer: transporters, treatment, and Trojan horses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple-negative breast cancer: therapeutic options

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary breast cancer phenotypes associated with propensity for central nervous system metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain metastases: the HER2 paradigm

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24735

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24735

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42463524&oldid=1958493760"